Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy
Lourdes M. Mendez, Ryan R. Posey, Pier Paolo Pandolfi
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib
Catherine C. Smith, Mark J. Levis, Alexander E. Perl, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2144-2155
Open Access | Times Cited: 54
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
Antti Kukkula, Veera K. Ojala, Lourdes M. Mendez, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4402-4402
Open Access | Times Cited: 49
The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker
Caroline Lo Presti, Florence Fauvelle, Marie‐Christine Jacob, et al.
Blood Advances (2021) Vol. 5, Iss. 1, pp. 156-166
Open Access | Times Cited: 34
The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia
Garrett M. Dancik, Lokman Varışlı, Spiros Vlahopoulos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9372-9372
Open Access | Times Cited: 15
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
Ji‐Yoon Noh, Huiyun Seo, Jungwoon Lee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8000-8000
Open Access | Times Cited: 33
Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia
Garrett M. Dancik, Ioannis F. Voutsas, Spiros Vlahopoulos
Molecular Biology Reports (2022) Vol. 49, Iss. 4, pp. 3321-3331
Open Access | Times Cited: 17
Diagnostic and Therapeutic Implications of the SUMOylation Pathway in Acute Myeloid Leukemia
Elena Chatzikalil, Konstantinos Arvanitakis, Filippos Filippatos, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 631-631
Open Access
Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
Xavier Roussel, Étienne Daguindau, Ana Berceanu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 19
Aldehyde Dehydrogenase Enzyme Functions in Acute Leukemia Stem Cells
Garrett M. Dancik, Ioannis F. Voutsas, Spiros Vlahopoulos
Frontiers in Bioscience-Scholar (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 10
How ITD Insertion Sites Orchestrate the Biology and Disease of FLT3-ITD-Mutated Acute Myeloid Leukemia
Tobias R. Haage, Burkhart Schraven, Dimitrios Mougiakakos, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2991-2991
Open Access | Times Cited: 6
Crosstalk between p53 modifiers at PML bodies
Sonja Matt, Thomas G. Hofmann
Molecular & Cellular Oncology (2015) Vol. 5, Iss. 3, pp. e1074335-e1074335
Open Access | Times Cited: 15
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
Fabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9159-9159
Open Access | Times Cited: 12
Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward
Joost B. Koedijk, Inge van der Werf, Friso Calkoen, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4364-4364
Open Access | Times Cited: 12
Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Georgios Petros Barakos, Eleftheria Hatzimichael
Diseases (2022) Vol. 10, Iss. 2, pp. 33-33
Open Access | Times Cited: 9
Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes
Giulio Cassanello, Raffaella Pasquale, Wilma Barcellini, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4941-4941
Open Access | Times Cited: 9
A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells
Barbara‐ann Guinn, Patrick J. Schuler, Hubert Schrezenmeier, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9285-9285
Open Access | Times Cited: 5
Comprehensive characterization of patient-derived xenograft models of pediatric leukemia
Anna Rogojina, Laura J. Klesse, Erin Butler, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108171-108171
Open Access | Times Cited: 5
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia
Feng‐Ting Dao, Jun Wang, Lu Yang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Immune-related lncRNAs pairs prognostic score model for prediction of survival in acute myeloid leukemia patients
Xue Liang, Cong Li, Mengmeng Fan, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4527-4538
Open Access | Times Cited: 3
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3− T cells represents a potential antitumor mechanism of azacitidine
Eleftheria Lamprianidou, Chryssoula Kordella, Anastasiya Kazachenka, et al.
Blood Advances (2021) Vol. 5, Iss. 1, pp. 129-142
Open Access | Times Cited: 7
MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations
Thibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 4, pp. 875-887
Closed Access | Times Cited: 7
Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia
Kyle Wiatrowski, Tae Hee Kim, Amanda Przespolewski
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
Li Fu, Jiao Cai, Jia Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis
Jun Wang, Feng‐Ting Dao, Lu Yang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia
Lei Bi, Shuangshuang Jia, Wuyue Hu, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top